THE USE OF PHOSPHODIESTERASE-5 INHIBITORS IN SECONDARY RAYNAUD'S PHENOMENON: A SYSTEMATIC REVIEW AND META-ANALYSIS

被引：0
|
作者：
Sin, Fang En [1 ]
Menon, Sanjeev [1 ]
Ridley, Martin [1 ]
机构：
[1] St Richards Hosp, Rheumatol, Chichester, England
来源：
RHEUMATOLOGY | 2016年 / 55卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
254
引用
收藏
页码：164 / 164
页数：1
相关论文
共 50 条
  • [1] PHOSPHODIESTERASE-5 INHIBITORS FOR THE TREATMENT OF SECONDARY RAYNAUD'S PHENOMENON: SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED TRIALS
    Roustit, Matthieu
    Blaise, Sophie
    Allanore, Yannick
    Carpentier, Patrick H.
    Caglayan, Evren
    Cracowski, Jean-Luc
    [J]. JOURNAL OF VASCULAR RESEARCH, 2013, 50 : 52 - 52
  • [2] PHOSPHODIESTERASE-5 INHIBITORS FOR THE TREATMENT OF SECONDARY RAYNAUD'S PHENOMENON: SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED TRIALS
    Roustit, M.
    Blaise, S.
    Allanore, Y.
    Carpentier, P. H.
    Caglayan, E.
    Cracowski, J. -L.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (02) : S25 - S25
  • [3] Phosphodiesterase-5 inhibitors for the treatment of secondary Raynaud's phenomenon: systematic review and meta-analysis of randomised trials
    Roustit, Matthieu
    Blaise, Sophie
    Allanore, Yannick
    Carpentier, Patrick H.
    Caglayan, Evren
    Cracowski, Jean-Luc
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 (10) : 1696 - 1699
  • [4] Phosphodiesterase-5 inhibitors for the treatment of secondary Raynaud's Phenomenon: systematic review and meta-analysis of randomized trials
    Roustit, M.
    Blaise, S.
    Allanore, Y.
    Carpentier, P.
    Caglayan, E.
    Cracowski, J. L.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2013, 27 : 111 - 112
  • [5] A Meta-Analysis of Phosphodiesterase 5 Inhibitors for the Treatment of Raynaud's Phenomenon
    Pope, Janet E.
    Rirash, Fadumo
    Tingey, Paul
    Harding, Sarah
    Maxwell, Lara J.
    Pardo, Jordi
    Ghogomu, Elizabeth
    Tugwell, Peter
    Wells, George A.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [6] Phosphodiesterase-5 inhibitors use and the risk of alzheimer's disease: a systematic review and meta-analysis
    Abouelmagd, Moaz Elsayed
    Abdelmeseh, Maickel
    Elrosasy, Amr
    Saad, Yousef Hesham
    Alnajjar, Asmaa Zakria
    Eid, Mahmoud
    Hassan, Atef
    Abbas, Abdallah
    [J]. NEUROLOGICAL SCIENCES, 2024,
  • [7] Phosphodiesterase-5 inhibitors relieve symptoms of severe Raynaud's Phenomenon
    Cheung, GTY
    Lau, CS
    Kumana, CR
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 313 - 313
  • [8] The Effect of Oral Phosphodiesterase-5 Inhibitors on Sperm Parameters: A Meta-analysis and Systematic Review
    Tan, Ping
    Liu, Liangren
    Wei, Shiyou
    Tang, Zhuang
    Yang, Lu
    Wei, Qiang
    [J]. UROLOGY, 2017, 105 : 54 - 61
  • [9] Effect of Phosphodiesterase-5 Inhibitors on the Treatment of Male Infertility: A Systematic Review and Meta-Analysis
    Dong, Liang
    Zhang, Xiaojin
    Yan, Xuhong
    Shen, Yifeng
    Li, Yulin
    Yu, Xujun
    [J]. WORLD JOURNAL OF MENS HEALTH, 2021, 39 (04): : 776 - 796
  • [10] Oral Phosphodiesterase-5 Inhibitors and Hormonal Treatments for Erectile Dysfunction: A Systematic Review and Meta-analysis
    Tsertsvadze, Alexander
    Fink, Howard A.
    Yazdi, Fatemeh
    MacDonald, Roderick
    Bella, Anthony J.
    Ansari, Mohammed T.
    Garritty, Chantelle
    Soares-Weiser, Karla
    Daniel, Raymond
    Sampson, Margaret
    Fox, Steven
    Moher, David
    Wilt, Timothy J.
    [J]. ANNALS OF INTERNAL MEDICINE, 2009, 151 (09) : 650 - W218
12345